Thank you, Mr. Chair.
I'd like to thank all the guests, but I will focus my questions and my intervention on Mr. Demers.
Of course, I think that there's probably not anyone in this room who hasn't been touched by cancer. Certainly moving forward in the many important areas that you've indicated is a priority. I have a health care background, and I think I've seen a lot of programs come and go. I've seen a lot of money spent, and I think there's a pretty good awareness of what we actually need to do in terms of prevention. The implications of chronic disease are such that if you look at any hospital, you'll see that nowadays probably 70% or 80% of their budget is spent on dealing with issues around chronic disease.
Maybe I'll give you time to articulate your brief more clearly. You talked about three areas, but you didn't talk specifically about what you'd like to do and how much money you think it would cost. I'll give you time to articulate a lot more clearly the prevention agenda and making prevention a priority.
We've talked about research capacity and the integration of research into policy and programming, which seems to have some real challenges, and then putting policy into practice, partnering with charities, and government leadership. Can you spend some time exploring all these ideas?